CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
7.50
2.18%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.24
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026262 %
Charges from full value of position ($-4.99)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026262%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00404 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00404%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 7.34
Open 7.28
1-Year Change -49.44%
Day's Range 7.28 - 7.66
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 12, 2024 7.34 0.38 5.46% 6.96 7.51 6.96
Jul 11, 2024 7.20 -0.36 -4.76% 7.56 7.76 7.16
Jul 10, 2024 7.52 0.45 6.36% 7.07 7.66 6.96
Jul 9, 2024 7.07 0.31 4.59% 6.76 7.13 6.42
Jul 8, 2024 6.74 0.02 0.30% 6.72 7.08 6.64
Jul 5, 2024 6.85 0.19 2.85% 6.66 7.06 6.62
Jul 3, 2024 6.59 0.12 1.85% 6.47 6.86 6.47
Jul 2, 2024 6.61 0.16 2.48% 6.45 7.01 6.45
Jul 1, 2024 6.72 -0.29 -4.14% 7.01 7.21 6.28
Jun 28, 2024 7.06 0.38 5.69% 6.68 7.46 6.37
Jun 27, 2024 6.41 0.63 10.90% 5.78 7.00 5.76
Jun 26, 2024 4.56 -0.08 -1.72% 4.64 4.69 4.13
Jun 25, 2024 4.64 0.00 0.00% 4.64 4.97 4.57
Jun 24, 2024 4.82 -0.70 -12.68% 5.52 5.52 4.82
Jun 21, 2024 5.37 -0.35 -6.12% 5.72 5.72 5.37
Jun 20, 2024 5.37 0.30 5.92% 5.07 5.42 5.05
Jun 18, 2024 5.22 -0.45 -7.94% 5.67 5.72 5.17
Jun 17, 2024 5.72 -0.15 -2.56% 5.87 5.97 5.72
Jun 14, 2024 5.91 0.04 0.68% 5.87 5.99 5.87
Jun 13, 2024 5.98 -0.14 -2.29% 6.12 6.22 5.72

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Kala Pharma Company profile

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for diseases of the eye. The Company's product candidate includes EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% and INVELTYS (loteprednol etabonate ophthalmic suspension) 1%. Its EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, is a short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, is a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. The Company's AMPPLIFY technology uses selectively-sized nanoparticles that each have a proprietary coating. Its Preclinical Development Programs include rTKI Program for Retinal Diseases (KPI-285/KPI-286), SEGRM Program and Surface Targeted Steroid Program (KPI-333).

Financial summary

BRIEF: For the nine months ended 30 September 2021, Kala Pharmaceuticals Inc revenues increased from $4.1M to $9.4M. Net loss increased 30% to $95M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects General and administrative - Balancing increase of 48% to $70.6M (expense), Stock-Based Compensation increase of 50% to $10.4M (expense).

Industry: Pharmaceuticals (NEC)

1167 Massachusetts Avenue
02476

People also watch

XRP/USD

0.54 Price
+1.160% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,421.58 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.60

US100

20,432.50 Price
+0.490% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

64,437.00 Price
+7.120% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading